Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elise Siegert

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Annals of the Rheumatic Diseases|May 13, 2017
Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosisChristian Beyer, Dörte Huscher, Andreas Ramming, et al.
JAMA Dermatology|June 28, 2023
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR DatabaseAlain Lescoat, Suiyuan Huang, Patricia E Carreira, et al.
Rheumatology (Oxford, England)|March 29, 2022
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohortElisabetta Zanatta, Dörte Huscher, Augusta Ortolan, et al.
Arthritis Care & Research|November 14, 2024
Oral Glucocorticoids for Skin Fibrosis in Early Diffuse Systemic Sclerosis: A Target Trial Emulation Study From the European Scleroderma Trials and Research Group DatabaseDenis Mongin, Marco Matucci-Cerinic, Ulrich A Walker, et al.
Rheumatology (Oxford, England)|September 13, 2022
Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR databaseMichele Iudici, Denis Mongin, Elise Siegert, et al.
Annals of the Rheumatic Diseases|February 25, 2025
Teclistamab in relapsed systemic sclerosis after autologous haematopoietic stem cell transplantationElise Siegert, Robert Biesen, Maria Dzamukova, et al.
Rheumatology (Oxford, England)|April 26, 2020
Older age onset of systemic sclerosis - accelerated disease progression in all disease subsetsPia Moinzadeh, Kathrin Kuhr, Elise Siegert, et al.
Arthritis Research & Therapy|November 1, 2024
Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysisAnja Wyss, Suzana Jordan, Nicole Graf, et al.
The Lancet. Rheumatology|January 24, 2024
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohortMuriel Elhai, Nanthara Sritharan, Marouane Boubaya, et al.
Annals of the Rheumatic Diseases|September 14, 2016
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity indexGabriele Valentini, Michele Iudici, Ulrich A Walker, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Annals of the Rheumatic Diseases|May 13, 2017
Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosisChristian Beyer, Dörte Huscher, Andreas Ramming, et al.
JAMA Dermatology|June 28, 2023
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR DatabaseAlain Lescoat, Suiyuan Huang, Patricia E Carreira, et al.
Rheumatology (Oxford, England)|March 29, 2022
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohortElisabetta Zanatta, Dörte Huscher, Augusta Ortolan, et al.
Arthritis Care & Research|November 14, 2024
Oral Glucocorticoids for Skin Fibrosis in Early Diffuse Systemic Sclerosis: A Target Trial Emulation Study From the European Scleroderma Trials and Research Group DatabaseDenis Mongin, Marco Matucci-Cerinic, Ulrich A Walker, et al.
Rheumatology (Oxford, England)|September 13, 2022
Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR databaseMichele Iudici, Denis Mongin, Elise Siegert, et al.
Annals of the Rheumatic Diseases|February 25, 2025
Teclistamab in relapsed systemic sclerosis after autologous haematopoietic stem cell transplantationElise Siegert, Robert Biesen, Maria Dzamukova, et al.
Rheumatology (Oxford, England)|April 26, 2020
Older age onset of systemic sclerosis - accelerated disease progression in all disease subsetsPia Moinzadeh, Kathrin Kuhr, Elise Siegert, et al.
Arthritis Research & Therapy|November 1, 2024
Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysisAnja Wyss, Suzana Jordan, Nicole Graf, et al.
The Lancet. Rheumatology|January 24, 2024
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohortMuriel Elhai, Nanthara Sritharan, Marouane Boubaya, et al.
Annals of the Rheumatic Diseases|September 14, 2016
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity indexGabriele Valentini, Michele Iudici, Ulrich A Walker, et al.
Pageof 8